search
Back to results

Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer (POSITIVE)

Primary Purpose

Early Breast Cancer

Status
Active
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
Endocrine therapy interruption
Sponsored by
ETOP IBCSG Partners Foundation
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Early Breast Cancer focused on measuring Premenopausal, endocrine responsive, Breast, Pregnancy

Eligibility Criteria

18 Years - 42 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Age ≥ 18 and ≤ 42 years at enrollment.
  • Has received adjuvant endocrine therapy (SERM alone, GnRH analogue plus SERM or AI) for ≥18 months but ≤30 months for early breast cancer.

Note: Patients who have received neo/adjuvant endocrine treatment within a clinical trial and patients who have received pharmaco-prevention are eligible.

  • The adjuvant endocrine therapy must have stopped within 1 month prior to enrollment.
  • Patient wishes to become pregnant. Note: Patients who have undergone oocyte/embryo/ovarian tissue cryopreservation at breast cancer diagnosis and/or have a previous history of assisted reproductive technology (ART) are eligible.
  • Breast cancer for which patient is receiving endocrine therapy must have been histologically-proven stage I-III, endocrine-responsive (i.e., estrogen and/or progesterone receptor positive, according to local definition of positive, determined using immunohistochemistry (IHC)), and treated with curative intent.

Note:

  • Patients with synchronous bilateral invasive breast cancer (diagnosed histologically within 2 months) are eligible.
  • Patient with invasive breast cancer or synchronous bilateral invasive breast cancer (diagnosed histologically within 2 months) during pregnancy are eligible.
  • Patients with BRCA1/2 mutations are eligible.
  • Patients could have received neo/adjuvant chemotherapy, or other systemic therapy (e.g., neo/adjuvant HER2-targeted therapy) according to institutional policy and patient's desire.
  • Patient must be premenopausal at breast cancer diagnosis, as determined locally and documented in patient record.
  • Patient must be without clinical evidence of loco-regional and distant disease, as evaluated according to institutional assessment standards and documented in the patient record.
  • Written informed consent (IC) for trial participation must be signed and dated by the patient and the investigator prior to enrollment.
  • Written consent to biological material submission, indicating the patient has been informed of and agrees to tissue and blood material use, transfer and handling, must be signed and dated by the patient and the investigator prior to any procedures specific for this trial.
  • The patient has been informed of and agrees to data transfer and handling, in accordance with national data protection guidelines.
  • Patient must be accessible for follow-up.

Exclusion Criteria:

  • Post-menopausal patients at BC diagnosis, as determined locally.
  • History of hysterectomy, bilateral oophorectomy or ovarian irradiation.
  • Patients with current local, loco-regional relapse and/or distant metastatic breast cancer.
  • Patients with a history of prior (ipsi- and/or contralateral) invasive BC.
  • Patients with previous or concomitant non-breast invasive malignancy.
  • Exceptions are limited exclusively to patients with the following previous malignancies, if adequately treated: basal or squamous cell carcinoma of the skin, in situ non-breast carcinoma, contra- or ipsilateral in situ breast carcinoma, stage Ia carcinoma of the cervix.
  • Concurrent disease or condition that would make the patient inappropriate for study participation or any serious medical disorder that would interfere with the patient's safety.
  • Patients with a history of noncompliance to medical treatments and/or considered potentially unreliable.
  • Patients with psychiatric, addictive, or any disorder that would prevent compliance with protocol requirements.

Sites / Locations

  • Cedars Sinai Medical Centre
  • Stanford Cancer Institute
  • Sharp Memorial Hospital
  • University of Colorado Cancer Centre - Anschutz Cancer Pavilion
  • Rocky Mountain Cancer Center
  • SCL Health Saint Joseph Hospital
  • Poudre Valley Hospital
  • Smilow Cancer Hospital-Derby Care Center
  • Smilow Cancer Hospital Care Center-Fairfield
  • Smilow Cancer Hospital Care Center at Saint Francis
  • Yale University - Yale Cancer Centre
  • Yale-New Haven Hospital North Haven Medical Center
  • Smilow Cancer Hospital-Orange Care Center
  • Smilow Cancer Hospital-Torrington Care Center
  • Smilow Cancer Hospital Care Center-Trumbull
  • Smilow Cancer Hospital-Waterbury Care Center
  • Helen F. Graham Cancer Center
  • Christiana Care Health System-Christiana Hospital
  • Medical Oncology Hematology Consultants PA
  • Regional Hematology Oncology Practice Associates
  • Georgetown University Hospital
  • Sibley Memorial Hospital
  • Emory University Hospital Midtown
  • Emory University
  • Straub Clinic and Hospital
  • OnCare Hawaii Inc - POB I
  • Queen's Medical Centre
  • OnCare Hawaii-Kuakini
  • John H Stroger Jr Hospital of Cook County
  • Carle on Vermilion
  • Carle Physician Group - Effingham
  • NorthShore University HealthSystem-Evanston Hospital
  • Northwestern University
  • NorthShore University Health System - Glenbrook Hospital
  • NorthShore Unversity Health System - Highland Park Hospital
  • Mattoon Charleston Primary Care
  • NorthShore Medical Centre
  • Carle Cancer Centre
  • The Carle Foundation Hospital
  • Indiana University
  • Greater Baltimore Medical Centre
  • Johns Hopkins University
  • Dana Farber Cancer Institute
  • Saint Joseph Mercy Hospital
  • IHA Hematology Consultants-Brighton
  • Saint Joseph Mercy Hospital - Brighton
  • IHA Hematology Consultants-Canton
  • Saint Joseph Mercy Hospital- Canton
  • IHA Hematology Consultants-Chelsea
  • Saint Joseph Mercy Hospital - Chelsea
  • IHA Hematology Oncology Consultants-Ann Arbor
  • Sanford Clinic North - Bemidji
  • Mercy Hospital
  • Essentia Health Cancer Center
  • Fairview Southdale Hospital
  • St John's Hospital
  • Abbott-Northwestern Hospital, 800 East 28th Street
  • Hennepin County Medical Center - Cancer Center
  • Mayo Clinic
  • Park Nicollet Methodist Hospital
  • Regions Hospital
  • Missouri Baptist Medical Center
  • Bozeman Deaconess Hospital
  • Dartmouth Hitchcock Medical Center/Norris Cotton Cancer Center
  • University of New Mexico Cancer Center
  • Montefiore Medical Center - Einstein Campus, 1695 Eastchester Road
  • Montefiore Medical Center-Weiler Hospital
  • Montefiore Medical Center - Moses Campus, 111 East 210th Street
  • Weill Medical College of Cornell University
  • SUNY Upstate Medical University
  • Dickstein Cancer Treatment Centre
  • UNC Lineberger Comprehensive Cancer Center
  • Southeastern Medical Oncology Centre
  • Southeastern Medical Oncology Centre
  • Margaret R Pardee Memorial Hospital
  • Southeastern Medical Oncology Centre
  • Southeastern Medical Oncology Centre
  • Sanford Bismark Medical Centre
  • Sanford Roger Maris Cancer Centre
  • Sanford Medical Centre
  • Case Western Reserve University
  • Ohio State University
  • Chagrin Highlands
  • UPMC-Magee Womens Hospital
  • Women and Infants Hospital of Rhode Island
  • Greenville Health System Cancer Institute-Butternut
  • Greenville Health System Cancer Institute-Faris
  • Greenville Health System Cancer Institute-Eastside
  • Greenville Health System Cancer Institute-Greer
  • Greenville Health System Cancer Institute-Seneca
  • Spartanburg Medical Center
  • Greenville Health System Cancer Institute-Spartanburg
  • Sanford Cancer Centre Oncology Clinic
  • Sanford USD Medical Centre - Sioux Falls
  • Doctor's Hospital of Laredo
  • Huntsman Cancer Institute / University of Utah
  • University of Vermont Medical Centre
  • Bon Secours Memorial Regional Medical Centre
  • Bon Secours Saint Francis Medical Centre
  • Bon Secours Saint Mary's Hospital
  • Fred Hutchinson Cancer Research Center
  • Seattle Cancer Care Alliance
  • University of Washington Medical Center
  • St John of God Subiaco Hospital
  • Univ. Klinik f. Frauenheilkunde u. Geburtshilfe
  • Univ. Klinik f. Frauenheilkunde Innsbruck
  • LKH Salzburg
  • Med. Univ. Klinik f. Chir
  • Cliniques Universitaires Saint-Luc
  • Cliniques Universitaires Saint-Luc Brussels
  • Institut Jules Bordet
  • UZ Leuven
  • C.H.U. Sart-Tilman
  • Clinique St.Elizabeth
  • Tom Baker Cancer Centre
  • Vancouver Cancer Centre
  • St Michael's Hospital
  • Mount Sinai Hospital
  • Odette Cancer Centre - Sunnybrook Health Sciences Centre
  • CHUM - Centre Hospitalier de l'Universite de Montreal
  • CHA-Hopital Du St-Sacrement
  • Centre Hospitalier Universitaire de Sherbrooke
  • Rigshospitalet
  • Institut Bergonie
  • Centre Oscar Lambret
  • French Lyon Cancer Center
  • APHP, Tenon Hospital in Paris
  • University General Hospital of Heraklion
  • Laso General Hospital, First Department of Medical Oncology
  • Debrecen University Dep. of Oncology
  • St. James's Hospital
  • St Vincent's University Hospital
  • Galway University Hospital
  • University Hospital Limerick
  • University Hospital Waterford
  • Shaare Zedek Medical Center
  • Chaim Sheba Medical Center
  • Ospedale di Prato
  • U.O Medicina Oncologica Ospedale di Carpi
  • Multimedica Spa
  • Centro di Riferimento Oncologico
  • Ospedale degli Infermi - S. C. Oncologia Medica
  • Azienda Sanitaria di Bolzano
  • Istituto Nazionale Ricerca Cancro
  • Istituto scientifico Romagnolo per lo studio e la cura
  • Istituto Europeo di Oncologia (IEO)
  • University of Eastern Piedmont
  • Salvatore Maugeri Foundation - Medical Oncology Unit
  • UO Oncologia, Rimini Hospital
  • Regina Elena National Cancer Institute
  • Ospedale di Trento
  • AO Universitaria Ospedale Di Circolo e Fondazione
  • Ospedale Belcolle di Viterbo
  • Kansai Rosai Hospital
  • Seirei Hamamatsu General Hospital
  • NHO Kyushu Cancer Centre, 3-1-1 Notame Minami-ku Fukuoka-shi
  • Social Medical Corporation Hakuaikai Sagara Hospital
  • St Marianna University School of Medicine Hospital
  • Kyoto University Hospital
  • NHO Shikoku Cancer Center
  • Toranomon Hospital
  • Kamiiida Daiichi General Hospital
  • Okayama University Hospital
  • Tohoku University Hospital
  • National Cancer Center for Global Medicine
  • National Cancer Center Hospital
  • Showa University Hospital
  • St Luke's International Hospital
  • The Cancer Institute Hospital of JFCR
  • University of Tsukuba
  • NHO Osaka National Hospital
  • Samsung Medical Center
  • Asan Medical Center
  • Seoul National University Hospital
  • American University of Beirut Medical Center
  • Leiden University Medical Centre, Albinusdreef 2, Postbus 9600
  • Norwegian Radium Hospital (Oslo University)
  • Champalimaud Cancer Center - Breast Cancer Unit
  • Institute of Oncology & Radiology of Serbia
  • Institute of Oncology Ljubljana - Medical Oncology Department
  • Hospital Clinico Universitario Virgen de la Arrixaca
  • Hospital Universitario Vall d'Hebron
  • Hospital General de Catalunya
  • Hospital Universitario Donostia
  • Instituto Catalán de Oncología de Gerona Hospital
  • Hospital Universitario HM Sanchinarro - Centro Integral Oncologico Clara Campal (CIOCC)
  • Hospital Clinico San Carlos
  • Hospital Universitario de Fuenlabrada
  • Hospital Clinico Universitario Virgen de la Victoria
  • Hospital Universitario Central de Asturias
  • Hospital Son Espases, Palma de Mallorca
  • Complejo Hospitalario de Navarra
  • Complejo Hospitalario Universitario de Santiago
  • Universitario Virgen del Rocio
  • Hospital Quiron Sagrado Corazon
  • Hospital Virgen De La Salud
  • Hospital General Universitario de Valencia - Servico Oncologia
  • Hospital Clinico Universitario Lozano Blesa
  • Spital STS AG Onkologiezentrum Thun-Berner Oberland
  • Kantonspital Baden AG
  • Universitätsspital Basel
  • Istituto Oncologico della Svizzera Italiana (IOSI)
  • Inselspital Bern
  • Oncocare Bern
  • Brustzentrum Thurgau - Obstetrics and Gynecology
  • University Hospital Geneva
  • University Hospital of Lausanne (CHUV) BH06 - Oncology Department
  • CHCVs Hôpital de Sion - Service d'oncologie ambulatoire
  • Brustzentum Kantonsspital St. Gallen
  • University Hospital Zurich
  • Brust-Zentrum AG

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Endocrine therapy interruption

Arm Description

Endocrine therapy interruption after having completed between ≥ 18 months and ≤ 30 months.

Outcomes

Primary Outcome Measures

Breast Cancer free interval (BCFI)
Kaplan-Meier Analysis

Secondary Outcome Measures

Information on Menstruation recovery and pattern
Menstrual diary
Pregnancy rate (determined by pregnancy test)
Pregnancy test
Pregnancy outcome
Labor and delivery Information, full term pregnancy, caesarean section, abortion, miscarriage, ectopic, stillbirth rates.
Offspring outcome
Collect information on preterm birth, low birth weight, births defects rates.
Breastfeeding pattern
Analysis of pattern e.g Duration, use of ipsilateral breast if previous breast conservation, side exclusivity
Use of assisted reproductive Technology (ART)
ART use will be tabulated
Distant recurrence-free interval (DRFI)
Kaplan-Meier Analysis

Full Information

First Posted
November 21, 2014
Last Updated
March 15, 2023
Sponsor
ETOP IBCSG Partners Foundation
Collaborators
Alliance for Clinical Trials in Oncology, Canadian Cancer Trials Group, Breast International Group
search

1. Study Identification

Unique Protocol Identification Number
NCT02308085
Brief Title
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Acronym
POSITIVE
Official Title
A Study Evaluating the Pregnancy Outcomes and Safety of Interrupting Endocrine Therapy for Young Women With Endocrine Responsive Breast Cancer Who Desire Pregnancy
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
December 4, 2014 (Actual)
Primary Completion Date
December 2025 (Anticipated)
Study Completion Date
December 2028 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
ETOP IBCSG Partners Foundation
Collaborators
Alliance for Clinical Trials in Oncology, Canadian Cancer Trials Group, Breast International Group

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The best available evidence suggests that pregnancy after breast cancer does not increase a woman's risk of developing a recurrence from her breast cancer. In particular, the most recent data suggest that this is the case also in women with a hormone receptor-positive breast cancer. There is also no indication of increased risk for delivery complications or for the newborn. The aim of the study is to investigate if temporary interruption of endocrine therapy, with the goal to permit pregnancy, is associated with a higher risk of breast cancer recurrence.The study aims also to evaluate different specific indicators related to fertility, pregnancy and breast cancer biology in young women. A psycho-oncological companion study on fertility concerns, psychological well-being and decisional conflicts will be conducted in interested Centers.
Detailed Description
Recent decades have witnessed a delay in childbearing for a variety of reasons including cultural, educational, and professional. As a consequence, breast cancer in young women often occurs before the completion of reproductive plans. Infertility has a significant impact on quality of life, resulting in substantial distress in younger women with breast cancer and influencing treatment decisions in a consistent proportion of patients.The best available evidence suggests that pregnancy after breast cancer does not increase a woman's risk of developing a recurrence.For women desiring pregnancy after a breast cancer, 5-10 years of endocrine therapy may substantially reduce the chance of conception; however, a shorter duration of endocrine therapy in this population has not been studied in a prospective manner. Birth outcome after breast cancer has not been shown to be different from that of the normal population, but increased risks of delivery complications, cesarean section, preterm birth and low birth weight have been reported. Endocrine agents are potentially teratogenic: taking into account their median half-life, waiting 3 months after their interruption before attempting conception is considered safe. The limited evidence available on breastfeeding after breast cancer reports successful lactation from the treated breast in approximately 30% of women without detrimental effect on survival. No prospective definitive data are available.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Early Breast Cancer
Keywords
Premenopausal, endocrine responsive, Breast, Pregnancy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
518 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Endocrine therapy interruption
Arm Type
Experimental
Arm Description
Endocrine therapy interruption after having completed between ≥ 18 months and ≤ 30 months.
Intervention Type
Other
Intervention Name(s)
Endocrine therapy interruption
Intervention Description
3 months wash-out between treatment interruption and pregnancy attempt. Up to 2 years interruption to allow pregnancy, delivery, breastfeeding or failure to conceive. Endocrine therapy resumption. Completion of full duration of endocrine therapy according to individual risk, institutional policy or patient's preference.
Primary Outcome Measure Information:
Title
Breast Cancer free interval (BCFI)
Description
Kaplan-Meier Analysis
Time Frame
From enrollment until the first invasive BC event, assessed up to 14 years
Secondary Outcome Measure Information:
Title
Information on Menstruation recovery and pattern
Description
Menstrual diary
Time Frame
Up to 24 months after enrollment
Title
Pregnancy rate (determined by pregnancy test)
Description
Pregnancy test
Time Frame
Up to 24 months after enrollment
Title
Pregnancy outcome
Description
Labor and delivery Information, full term pregnancy, caesarean section, abortion, miscarriage, ectopic, stillbirth rates.
Time Frame
Up to 33 months after enrollment
Title
Offspring outcome
Description
Collect information on preterm birth, low birth weight, births defects rates.
Time Frame
Up to 33 months after enrollment
Title
Breastfeeding pattern
Description
Analysis of pattern e.g Duration, use of ipsilateral breast if previous breast conservation, side exclusivity
Time Frame
Up to 36 months after enrollment
Title
Use of assisted reproductive Technology (ART)
Description
ART use will be tabulated
Time Frame
Up to 24 months after enrollment
Title
Distant recurrence-free interval (DRFI)
Description
Kaplan-Meier Analysis
Time Frame
Time from enrollment in the study to the first breast cancer recurrence in a distant site, assessed up to 14 years

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
42 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age ≥ 18 and ≤ 42 years at enrollment. Has received adjuvant endocrine therapy (SERM alone, GnRH analogue plus SERM or AI) for ≥18 months but ≤30 months for early breast cancer. Note: Patients who have received neo/adjuvant endocrine treatment within a clinical trial and patients who have received pharmaco-prevention are eligible. The adjuvant endocrine therapy must have stopped within 1 month prior to enrollment. Patient wishes to become pregnant. Note: Patients who have undergone oocyte/embryo/ovarian tissue cryopreservation at breast cancer diagnosis and/or have a previous history of assisted reproductive technology (ART) are eligible. Breast cancer for which patient is receiving endocrine therapy must have been histologically-proven stage I-III, endocrine-responsive (i.e., estrogen and/or progesterone receptor positive, according to local definition of positive, determined using immunohistochemistry (IHC)), and treated with curative intent. Note: Patients with synchronous bilateral invasive breast cancer (diagnosed histologically within 2 months) are eligible. Patient with invasive breast cancer or synchronous bilateral invasive breast cancer (diagnosed histologically within 2 months) during pregnancy are eligible. Patients with BRCA1/2 mutations are eligible. Patients could have received neo/adjuvant chemotherapy, or other systemic therapy (e.g., neo/adjuvant HER2-targeted therapy) according to institutional policy and patient's desire. Patient must be premenopausal at breast cancer diagnosis, as determined locally and documented in patient record. Patient must be without clinical evidence of loco-regional and distant disease, as evaluated according to institutional assessment standards and documented in the patient record. Written informed consent (IC) for trial participation must be signed and dated by the patient and the investigator prior to enrollment. Written consent to biological material submission, indicating the patient has been informed of and agrees to tissue and blood material use, transfer and handling, must be signed and dated by the patient and the investigator prior to any procedures specific for this trial. The patient has been informed of and agrees to data transfer and handling, in accordance with national data protection guidelines. Patient must be accessible for follow-up. Exclusion Criteria: Post-menopausal patients at BC diagnosis, as determined locally. History of hysterectomy, bilateral oophorectomy or ovarian irradiation. Patients with current local, loco-regional relapse and/or distant metastatic breast cancer. Patients with a history of prior (ipsi- and/or contralateral) invasive BC. Patients with previous or concomitant non-breast invasive malignancy. Exceptions are limited exclusively to patients with the following previous malignancies, if adequately treated: basal or squamous cell carcinoma of the skin, in situ non-breast carcinoma, contra- or ipsilateral in situ breast carcinoma, stage Ia carcinoma of the cervix. Concurrent disease or condition that would make the patient inappropriate for study participation or any serious medical disorder that would interfere with the patient's safety. Patients with a history of noncompliance to medical treatments and/or considered potentially unreliable. Patients with psychiatric, addictive, or any disorder that would prevent compliance with protocol requirements.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Olivia Pagani, MD
Organizational Affiliation
Oncology Institue of Southern Switzerland (IOSI)
Official's Role
Study Chair
Facility Information:
Facility Name
Cedars Sinai Medical Centre
City
Los Angeles
State/Province
California
ZIP/Postal Code
90211
Country
United States
Facility Name
Stanford Cancer Institute
City
Palo Alto
State/Province
California
ZIP/Postal Code
94305
Country
United States
Facility Name
Sharp Memorial Hospital
City
San Diego
State/Province
California
Country
United States
Facility Name
University of Colorado Cancer Centre - Anschutz Cancer Pavilion
City
Aurora
State/Province
Colorado
ZIP/Postal Code
80045
Country
United States
Facility Name
Rocky Mountain Cancer Center
City
Boulder
State/Province
Colorado
ZIP/Postal Code
80303
Country
United States
Facility Name
SCL Health Saint Joseph Hospital
City
Denver
State/Province
Colorado
ZIP/Postal Code
80218
Country
United States
Facility Name
Poudre Valley Hospital
City
Fort Collins
State/Province
Colorado
ZIP/Postal Code
80524
Country
United States
Facility Name
Smilow Cancer Hospital-Derby Care Center
City
Derby
State/Province
Connecticut
ZIP/Postal Code
06418
Country
United States
Facility Name
Smilow Cancer Hospital Care Center-Fairfield
City
Fairfield
State/Province
Connecticut
ZIP/Postal Code
06824
Country
United States
Facility Name
Smilow Cancer Hospital Care Center at Saint Francis
City
Hartford
State/Province
Connecticut
ZIP/Postal Code
06105
Country
United States
Facility Name
Yale University - Yale Cancer Centre
City
New Haven
State/Province
Connecticut
ZIP/Postal Code
06520
Country
United States
Facility Name
Yale-New Haven Hospital North Haven Medical Center
City
North Haven
State/Province
Connecticut
ZIP/Postal Code
06473
Country
United States
Facility Name
Smilow Cancer Hospital-Orange Care Center
City
Orange
State/Province
Connecticut
ZIP/Postal Code
06477
Country
United States
Facility Name
Smilow Cancer Hospital-Torrington Care Center
City
Torrington
State/Province
Connecticut
ZIP/Postal Code
06790
Country
United States
Facility Name
Smilow Cancer Hospital Care Center-Trumbull
City
Trumbull
State/Province
Connecticut
ZIP/Postal Code
06611
Country
United States
Facility Name
Smilow Cancer Hospital-Waterbury Care Center
City
Waterbury
State/Province
Connecticut
ZIP/Postal Code
06708
Country
United States
Facility Name
Helen F. Graham Cancer Center
City
Newark
State/Province
Delaware
ZIP/Postal Code
19713
Country
United States
Facility Name
Christiana Care Health System-Christiana Hospital
City
Newark
State/Province
Delaware
ZIP/Postal Code
19718
Country
United States
Facility Name
Medical Oncology Hematology Consultants PA
City
Newport
State/Province
Delaware
ZIP/Postal Code
19713
Country
United States
Facility Name
Regional Hematology Oncology Practice Associates
City
Newport
State/Province
Delaware
ZIP/Postal Code
19713
Country
United States
Facility Name
Georgetown University Hospital
City
Washington
State/Province
District of Columbia
ZIP/Postal Code
20007
Country
United States
Facility Name
Sibley Memorial Hospital
City
Washington
State/Province
District of Columbia
ZIP/Postal Code
20016
Country
United States
Facility Name
Emory University Hospital Midtown
City
Atlanta
State/Province
Georgia
ZIP/Postal Code
30308
Country
United States
Facility Name
Emory University
City
Atlanta
State/Province
Georgia
ZIP/Postal Code
30322
Country
United States
Facility Name
Straub Clinic and Hospital
City
Honolulu
State/Province
Hawaii
ZIP/Postal Code
96701
Country
United States
Facility Name
OnCare Hawaii Inc - POB I
City
Honolulu
State/Province
Hawaii
ZIP/Postal Code
96813
Country
United States
Facility Name
Queen's Medical Centre
City
Honolulu
State/Province
Hawaii
ZIP/Postal Code
96813
Country
United States
Facility Name
OnCare Hawaii-Kuakini
City
Honolulu
State/Province
Hawaii
ZIP/Postal Code
96817
Country
United States
Facility Name
John H Stroger Jr Hospital of Cook County
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60612
Country
United States
Facility Name
Carle on Vermilion
City
Danville
State/Province
Illinois
ZIP/Postal Code
61832
Country
United States
Facility Name
Carle Physician Group - Effingham
City
Effingham
State/Province
Illinois
ZIP/Postal Code
62401
Country
United States
Facility Name
NorthShore University HealthSystem-Evanston Hospital
City
Evanston
State/Province
Illinois
ZIP/Postal Code
60201
Country
United States
Facility Name
Northwestern University
City
Evanston
State/Province
Illinois
ZIP/Postal Code
60201
Country
United States
Facility Name
NorthShore University Health System - Glenbrook Hospital
City
Glenview
State/Province
Illinois
ZIP/Postal Code
60026
Country
United States
Facility Name
NorthShore Unversity Health System - Highland Park Hospital
City
Highland Park
State/Province
Illinois
ZIP/Postal Code
60035
Country
United States
Facility Name
Mattoon Charleston Primary Care
City
Mattoon
State/Province
Illinois
ZIP/Postal Code
61938
Country
United States
Facility Name
NorthShore Medical Centre
City
Skokie
State/Province
Illinois
ZIP/Postal Code
60076
Country
United States
Facility Name
Carle Cancer Centre
City
Urbana
State/Province
Illinois
ZIP/Postal Code
61801
Country
United States
Facility Name
The Carle Foundation Hospital
City
Urbana
State/Province
Illinois
ZIP/Postal Code
61801
Country
United States
Facility Name
Indiana University
City
Indianapolis
State/Province
Indiana
ZIP/Postal Code
46202
Country
United States
Facility Name
Greater Baltimore Medical Centre
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21204
Country
United States
Facility Name
Johns Hopkins University
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21218
Country
United States
Facility Name
Dana Farber Cancer Institute
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02215-5450
Country
United States
Facility Name
Saint Joseph Mercy Hospital
City
Ann Arbor
State/Province
Michigan
ZIP/Postal Code
48103
Country
United States
Facility Name
IHA Hematology Consultants-Brighton
City
Brighton
State/Province
Michigan
ZIP/Postal Code
48114
Country
United States
Facility Name
Saint Joseph Mercy Hospital - Brighton
City
Brighton
State/Province
Michigan
ZIP/Postal Code
48114
Country
United States
Facility Name
IHA Hematology Consultants-Canton
City
Canton
State/Province
Michigan
ZIP/Postal Code
48188
Country
United States
Facility Name
Saint Joseph Mercy Hospital- Canton
City
Canton
State/Province
Michigan
ZIP/Postal Code
48188
Country
United States
Facility Name
IHA Hematology Consultants-Chelsea
City
Chelsea
State/Province
Michigan
ZIP/Postal Code
48118
Country
United States
Facility Name
Saint Joseph Mercy Hospital - Chelsea
City
Chelsea
State/Province
Michigan
ZIP/Postal Code
48118
Country
United States
Facility Name
IHA Hematology Oncology Consultants-Ann Arbor
City
Ypsilanti
State/Province
Michigan
ZIP/Postal Code
48198
Country
United States
Facility Name
Sanford Clinic North - Bemidji
City
Bemidji
State/Province
Minnesota
ZIP/Postal Code
56501
Country
United States
Facility Name
Mercy Hospital
City
Coon Rapids
State/Province
Minnesota
ZIP/Postal Code
55433
Country
United States
Facility Name
Essentia Health Cancer Center
City
Duluth
State/Province
Minnesota
ZIP/Postal Code
55805-1951
Country
United States
Facility Name
Fairview Southdale Hospital
City
Edina
State/Province
Minnesota
ZIP/Postal Code
55435
Country
United States
Facility Name
St John's Hospital
City
Maplewood
State/Province
Minnesota
ZIP/Postal Code
55109
Country
United States
Facility Name
Abbott-Northwestern Hospital, 800 East 28th Street
City
Minneapolis
State/Province
Minnesota
ZIP/Postal Code
55407
Country
United States
Facility Name
Hennepin County Medical Center - Cancer Center
City
Minneapolis
State/Province
Minnesota
ZIP/Postal Code
55415
Country
United States
Facility Name
Mayo Clinic
City
Rochester
State/Province
Minnesota
ZIP/Postal Code
55902
Country
United States
Facility Name
Park Nicollet Methodist Hospital
City
Saint Louis Park
State/Province
Minnesota
ZIP/Postal Code
55343
Country
United States
Facility Name
Regions Hospital
City
Saint Paul
State/Province
Minnesota
ZIP/Postal Code
55101
Country
United States
Facility Name
Missouri Baptist Medical Center
City
Saint Louis
State/Province
Missouri
ZIP/Postal Code
63131
Country
United States
Facility Name
Bozeman Deaconess Hospital
City
Bozeman
State/Province
Montana
ZIP/Postal Code
59715
Country
United States
Facility Name
Dartmouth Hitchcock Medical Center/Norris Cotton Cancer Center
City
Lebanon
State/Province
New Hampshire
ZIP/Postal Code
03756
Country
United States
Facility Name
University of New Mexico Cancer Center
City
Albuquerque
State/Province
New Mexico
ZIP/Postal Code
87131
Country
United States
Facility Name
Montefiore Medical Center - Einstein Campus, 1695 Eastchester Road
City
Bronx
State/Province
New York
ZIP/Postal Code
10461
Country
United States
Facility Name
Montefiore Medical Center-Weiler Hospital
City
Bronx
State/Province
New York
ZIP/Postal Code
10461
Country
United States
Facility Name
Montefiore Medical Center - Moses Campus, 111 East 210th Street
City
Bronx
State/Province
New York
ZIP/Postal Code
10467
Country
United States
Facility Name
Weill Medical College of Cornell University
City
New York
State/Province
New York
ZIP/Postal Code
10065
Country
United States
Facility Name
SUNY Upstate Medical University
City
Syracuse
State/Province
New York
ZIP/Postal Code
13210
Country
United States
Facility Name
Dickstein Cancer Treatment Centre
City
White Plains
State/Province
New York
ZIP/Postal Code
10601
Country
United States
Facility Name
UNC Lineberger Comprehensive Cancer Center
City
Chapel Hill
State/Province
North Carolina
ZIP/Postal Code
27599
Country
United States
Facility Name
Southeastern Medical Oncology Centre
City
Clinton
State/Province
North Carolina
ZIP/Postal Code
28328
Country
United States
Facility Name
Southeastern Medical Oncology Centre
City
Goldsboro
State/Province
North Carolina
ZIP/Postal Code
27534
Country
United States
Facility Name
Margaret R Pardee Memorial Hospital
City
Hendersonville
State/Province
North Carolina
Country
United States
Facility Name
Southeastern Medical Oncology Centre
City
Jacksonville
State/Province
North Carolina
ZIP/Postal Code
28546
Country
United States
Facility Name
Southeastern Medical Oncology Centre
City
Wilson
State/Province
North Carolina
ZIP/Postal Code
27534
Country
United States
Facility Name
Sanford Bismark Medical Centre
City
Bismarck
State/Province
North Dakota
ZIP/Postal Code
58501
Country
United States
Facility Name
Sanford Roger Maris Cancer Centre
City
Fargo
State/Province
North Dakota
ZIP/Postal Code
58102
Country
United States
Facility Name
Sanford Medical Centre
City
Fargo
State/Province
North Dakota
ZIP/Postal Code
58122
Country
United States
Facility Name
Case Western Reserve University
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44106
Country
United States
Facility Name
Ohio State University
City
Columbus
State/Province
Ohio
ZIP/Postal Code
43210
Country
United States
Facility Name
Chagrin Highlands
City
Orange Village
State/Province
Ohio
ZIP/Postal Code
44122
Country
United States
Facility Name
UPMC-Magee Womens Hospital
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15213
Country
United States
Facility Name
Women and Infants Hospital of Rhode Island
City
Providence
State/Province
Rhode Island
ZIP/Postal Code
02905
Country
United States
Facility Name
Greenville Health System Cancer Institute-Butternut
City
Greenville
State/Province
South Carolina
ZIP/Postal Code
29605
Country
United States
Facility Name
Greenville Health System Cancer Institute-Faris
City
Greenville
State/Province
South Carolina
ZIP/Postal Code
29605
Country
United States
Facility Name
Greenville Health System Cancer Institute-Eastside
City
Greenville
State/Province
South Carolina
ZIP/Postal Code
29611
Country
United States
Facility Name
Greenville Health System Cancer Institute-Greer
City
Greer
State/Province
South Carolina
ZIP/Postal Code
29650
Country
United States
Facility Name
Greenville Health System Cancer Institute-Seneca
City
Seneca
State/Province
South Carolina
ZIP/Postal Code
29672
Country
United States
Facility Name
Spartanburg Medical Center
City
Spartanburg
State/Province
South Carolina
ZIP/Postal Code
29303
Country
United States
Facility Name
Greenville Health System Cancer Institute-Spartanburg
City
Spartanburg
State/Province
South Carolina
ZIP/Postal Code
29307
Country
United States
Facility Name
Sanford Cancer Centre Oncology Clinic
City
Sioux Falls
State/Province
South Dakota
ZIP/Postal Code
57104
Country
United States
Facility Name
Sanford USD Medical Centre - Sioux Falls
City
Sioux Falls
State/Province
South Dakota
ZIP/Postal Code
57104
Country
United States
Facility Name
Doctor's Hospital of Laredo
City
Laredo
State/Province
Texas
ZIP/Postal Code
78045
Country
United States
Facility Name
Huntsman Cancer Institute / University of Utah
City
Salt Lake City
State/Province
Utah
ZIP/Postal Code
84112
Country
United States
Facility Name
University of Vermont Medical Centre
City
Burlington
State/Province
Vermont
ZIP/Postal Code
05401
Country
United States
Facility Name
Bon Secours Memorial Regional Medical Centre
City
Mechanicsville
State/Province
Virginia
ZIP/Postal Code
23116
Country
United States
Facility Name
Bon Secours Saint Francis Medical Centre
City
Midlothian
State/Province
Virginia
ZIP/Postal Code
23114
Country
United States
Facility Name
Bon Secours Saint Mary's Hospital
City
Richmond
State/Province
Virginia
ZIP/Postal Code
23223
Country
United States
Facility Name
Fred Hutchinson Cancer Research Center
City
Seattle
State/Province
Washington
ZIP/Postal Code
98109
Country
United States
Facility Name
Seattle Cancer Care Alliance
City
Seattle
State/Province
Washington
ZIP/Postal Code
98109
Country
United States
Facility Name
University of Washington Medical Center
City
Seattle
State/Province
Washington
ZIP/Postal Code
98195
Country
United States
Facility Name
St John of God Subiaco Hospital
City
Perth
State/Province
Western Australia
ZIP/Postal Code
6008
Country
Australia
Facility Name
Univ. Klinik f. Frauenheilkunde u. Geburtshilfe
City
Graz
ZIP/Postal Code
8036
Country
Austria
Facility Name
Univ. Klinik f. Frauenheilkunde Innsbruck
City
Innsbruck
ZIP/Postal Code
6020
Country
Austria
Facility Name
LKH Salzburg
City
Salzburg
ZIP/Postal Code
5020
Country
Austria
Facility Name
Med. Univ. Klinik f. Chir
City
Vienna
ZIP/Postal Code
1090
Country
Austria
Facility Name
Cliniques Universitaires Saint-Luc
City
Brussels
ZIP/Postal Code
1200
Country
Belgium
Facility Name
Cliniques Universitaires Saint-Luc Brussels
City
Brussels
Country
Belgium
Facility Name
Institut Jules Bordet
City
Brussels
Country
Belgium
Facility Name
UZ Leuven
City
Leuven
ZIP/Postal Code
3000
Country
Belgium
Facility Name
C.H.U. Sart-Tilman
City
Liege
ZIP/Postal Code
4000
Country
Belgium
Facility Name
Clinique St.Elizabeth
City
Namur
ZIP/Postal Code
5000
Country
Belgium
Facility Name
Tom Baker Cancer Centre
City
Calgary
State/Province
Alberta
ZIP/Postal Code
T2N 4N2
Country
Canada
Facility Name
Vancouver Cancer Centre
City
Vancouver
State/Province
British Columbia
ZIP/Postal Code
V5Z 1M9
Country
Canada
Facility Name
St Michael's Hospital
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5B 1W8
Country
Canada
Facility Name
Mount Sinai Hospital
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5G 1X5
Country
Canada
Facility Name
Odette Cancer Centre - Sunnybrook Health Sciences Centre
City
Toronto
State/Province
Ontario
Country
Canada
Facility Name
CHUM - Centre Hospitalier de l'Universite de Montreal
City
Montréal
State/Province
Quebec
ZIP/Postal Code
H2X 3E4
Country
Canada
Facility Name
CHA-Hopital Du St-Sacrement
City
Quebec City
State/Province
Quebec
ZIP/Postal Code
G1S 4L8
Country
Canada
Facility Name
Centre Hospitalier Universitaire de Sherbrooke
City
Sherbrooke
State/Province
Quebec
Country
Canada
Facility Name
Rigshospitalet
City
København
ZIP/Postal Code
2100
Country
Denmark
Facility Name
Institut Bergonie
City
Bordeaux
ZIP/Postal Code
33076
Country
France
Facility Name
Centre Oscar Lambret
City
Lille
ZIP/Postal Code
59020
Country
France
Facility Name
French Lyon Cancer Center
City
Lyon
ZIP/Postal Code
69373
Country
France
Facility Name
APHP, Tenon Hospital in Paris
City
Paris
Country
France
Facility Name
University General Hospital of Heraklion
City
Stavrakia
State/Province
Crete
ZIP/Postal Code
71110
Country
Greece
Facility Name
Laso General Hospital, First Department of Medical Oncology
City
Athens
Country
Greece
Facility Name
Debrecen University Dep. of Oncology
City
Debrecen
Country
Hungary
Facility Name
St. James's Hospital
City
Dublin 8
Country
Ireland
Facility Name
St Vincent's University Hospital
City
Dublin
Country
Ireland
Facility Name
Galway University Hospital
City
Galway
Country
Ireland
Facility Name
University Hospital Limerick
City
Limerick
Country
Ireland
Facility Name
University Hospital Waterford
City
Waterford
Country
Ireland
Facility Name
Shaare Zedek Medical Center
City
Jerusalem
Country
Israel
Facility Name
Chaim Sheba Medical Center
City
Tel Hashomer
ZIP/Postal Code
5265601
Country
Israel
Facility Name
Ospedale di Prato
City
Prato
State/Province
Firenze
Country
Italy
Facility Name
U.O Medicina Oncologica Ospedale di Carpi
City
Carpi
State/Province
Modena
ZIP/Postal Code
41012
Country
Italy
Facility Name
Multimedica Spa
City
Castellanza
State/Province
Vareze
Country
Italy
Facility Name
Centro di Riferimento Oncologico
City
Aviano
ZIP/Postal Code
33081
Country
Italy
Facility Name
Ospedale degli Infermi - S. C. Oncologia Medica
City
Biella
Country
Italy
Facility Name
Azienda Sanitaria di Bolzano
City
Bolzano
ZIP/Postal Code
39100
Country
Italy
Facility Name
Istituto Nazionale Ricerca Cancro
City
Genova
Country
Italy
Facility Name
Istituto scientifico Romagnolo per lo studio e la cura
City
Meldola
Country
Italy
Facility Name
Istituto Europeo di Oncologia (IEO)
City
Milan
ZIP/Postal Code
20141
Country
Italy
Facility Name
University of Eastern Piedmont
City
Novara
ZIP/Postal Code
28100
Country
Italy
Facility Name
Salvatore Maugeri Foundation - Medical Oncology Unit
City
Pavia
ZIP/Postal Code
27100
Country
Italy
Facility Name
UO Oncologia, Rimini Hospital
City
Rimini
ZIP/Postal Code
47923
Country
Italy
Facility Name
Regina Elena National Cancer Institute
City
Rome
Country
Italy
Facility Name
Ospedale di Trento
City
Trento
ZIP/Postal Code
38122
Country
Italy
Facility Name
AO Universitaria Ospedale Di Circolo e Fondazione
City
Varese
ZIP/Postal Code
21100
Country
Italy
Facility Name
Ospedale Belcolle di Viterbo
City
Viterbo
Country
Italy
Facility Name
Kansai Rosai Hospital
City
Amagasaki
State/Province
Hyogo
ZIP/Postal Code
660-8511
Country
Japan
Facility Name
Seirei Hamamatsu General Hospital
City
Hamamatsu
State/Province
Shizuoka
Country
Japan
Facility Name
NHO Kyushu Cancer Centre, 3-1-1 Notame Minami-ku Fukuoka-shi
City
Fukuoka
ZIP/Postal Code
811-1395
Country
Japan
Facility Name
Social Medical Corporation Hakuaikai Sagara Hospital
City
Kagoshima
Country
Japan
Facility Name
St Marianna University School of Medicine Hospital
City
Kawasaki
Country
Japan
Facility Name
Kyoto University Hospital
City
Kyoto
Country
Japan
Facility Name
NHO Shikoku Cancer Center
City
Matsuyama
Country
Japan
Facility Name
Toranomon Hospital
City
Minato-ku, Tokyo
ZIP/Postal Code
105-8470
Country
Japan
Facility Name
Kamiiida Daiichi General Hospital
City
Nagoya
ZIP/Postal Code
463-0802
Country
Japan
Facility Name
Okayama University Hospital
City
Okayama
Country
Japan
Facility Name
Tohoku University Hospital
City
Sendai
Country
Japan
Facility Name
National Cancer Center for Global Medicine
City
Tokyo
Country
Japan
Facility Name
National Cancer Center Hospital
City
Tokyo
Country
Japan
Facility Name
Showa University Hospital
City
Tokyo
Country
Japan
Facility Name
St Luke's International Hospital
City
Tokyo
Country
Japan
Facility Name
The Cancer Institute Hospital of JFCR
City
Tokyo
Country
Japan
Facility Name
University of Tsukuba
City
Tsukuba
Country
Japan
Facility Name
NHO Osaka National Hospital
City
Ōsaka
Country
Japan
Facility Name
Samsung Medical Center
City
Seoul
ZIP/Postal Code
06351
Country
Korea, Republic of
Facility Name
Asan Medical Center
City
Seoul
Country
Korea, Republic of
Facility Name
Seoul National University Hospital
City
Seoul
Country
Korea, Republic of
Facility Name
American University of Beirut Medical Center
City
Beirut
Country
Lebanon
Facility Name
Leiden University Medical Centre, Albinusdreef 2, Postbus 9600
City
Leiden
ZIP/Postal Code
2300 RC
Country
Netherlands
Facility Name
Norwegian Radium Hospital (Oslo University)
City
Oslo
Country
Norway
Facility Name
Champalimaud Cancer Center - Breast Cancer Unit
City
Lisbon
Country
Portugal
Facility Name
Institute of Oncology & Radiology of Serbia
City
Belgrade
Country
Serbia
Facility Name
Institute of Oncology Ljubljana - Medical Oncology Department
City
Ljubljana
Country
Slovenia
Facility Name
Hospital Clinico Universitario Virgen de la Arrixaca
City
El Palmar
State/Province
Murcia
Country
Spain
Facility Name
Hospital Universitario Vall d'Hebron
City
Barcelona
ZIP/Postal Code
08035
Country
Spain
Facility Name
Hospital General de Catalunya
City
Barcelona
Country
Spain
Facility Name
Hospital Universitario Donostia
City
Donostia
Country
Spain
Facility Name
Instituto Catalán de Oncología de Gerona Hospital
City
Gerona
Country
Spain
Facility Name
Hospital Universitario HM Sanchinarro - Centro Integral Oncologico Clara Campal (CIOCC)
City
Madrid
ZIP/Postal Code
28050
Country
Spain
Facility Name
Hospital Clinico San Carlos
City
Madrid
Country
Spain
Facility Name
Hospital Universitario de Fuenlabrada
City
Madrid
Country
Spain
Facility Name
Hospital Clinico Universitario Virgen de la Victoria
City
Málaga
ZIP/Postal Code
29010
Country
Spain
Facility Name
Hospital Universitario Central de Asturias
City
Oviedo
Country
Spain
Facility Name
Hospital Son Espases, Palma de Mallorca
City
Palma
Country
Spain
Facility Name
Complejo Hospitalario de Navarra
City
Pamplona
Country
Spain
Facility Name
Complejo Hospitalario Universitario de Santiago
City
Santiago de Compostela
Country
Spain
Facility Name
Universitario Virgen del Rocio
City
Sevilla
ZIP/Postal Code
41013
Country
Spain
Facility Name
Hospital Quiron Sagrado Corazon
City
Sevilla
Country
Spain
Facility Name
Hospital Virgen De La Salud
City
Toledo
Country
Spain
Facility Name
Hospital General Universitario de Valencia - Servico Oncologia
City
Valencia
Country
Spain
Facility Name
Hospital Clinico Universitario Lozano Blesa
City
Zaragoza
Country
Spain
Facility Name
Spital STS AG Onkologiezentrum Thun-Berner Oberland
City
Thun
State/Province
Bern
ZIP/Postal Code
3600
Country
Switzerland
Facility Name
Kantonspital Baden AG
City
Baden
ZIP/Postal Code
5404
Country
Switzerland
Facility Name
Universitätsspital Basel
City
Basel
ZIP/Postal Code
4031
Country
Switzerland
Facility Name
Istituto Oncologico della Svizzera Italiana (IOSI)
City
Bellinzona
Country
Switzerland
Facility Name
Inselspital Bern
City
Bern
ZIP/Postal Code
3010
Country
Switzerland
Facility Name
Oncocare Bern
City
Bern
ZIP/Postal Code
3012
Country
Switzerland
Facility Name
Brustzentrum Thurgau - Obstetrics and Gynecology
City
Frauenfeld
Country
Switzerland
Facility Name
University Hospital Geneva
City
Genève
ZIP/Postal Code
1211
Country
Switzerland
Facility Name
University Hospital of Lausanne (CHUV) BH06 - Oncology Department
City
Lausanne
Country
Switzerland
Facility Name
CHCVs Hôpital de Sion - Service d'oncologie ambulatoire
City
Sion
ZIP/Postal Code
736
Country
Switzerland
Facility Name
Brustzentum Kantonsspital St. Gallen
City
St. Gallen
ZIP/Postal Code
9007
Country
Switzerland
Facility Name
University Hospital Zurich
City
Zurich
ZIP/Postal Code
8091
Country
Switzerland
Facility Name
Brust-Zentrum AG
City
Zürich
ZIP/Postal Code
8008
Country
Switzerland

12. IPD Sharing Statement

Citations:
PubMed Identifier
19001605
Citation
Brinton LA, Sherman ME, Carreon JD, Anderson WF. Recent trends in breast cancer among younger women in the United States. J Natl Cancer Inst. 2008 Nov 19;100(22):1643-8. doi: 10.1093/jnci/djn344. Epub 2008 Nov 11.
Results Reference
background
PubMed Identifier
23768969
Citation
Leclere B, Molinie F, Tretarre B, Stracci F, Daubisse-Marliac L, Colonna M; GRELL Working Group. Trends in incidence of breast cancer among women under 40 in seven European countries: a GRELL cooperative study. Cancer Epidemiol. 2013 Oct;37(5):544-9. doi: 10.1016/j.canep.2013.05.001. Epub 2013 Jun 12. Erratum In: Cancer Epidemiol. 2014 Feb;38(1):106. GRELL Working Group [added]; multiple investigator names added.
Results Reference
background
PubMed Identifier
17960621
Citation
Bentzon N, During M, Rasmussen BB, Mouridsen H, Kroman N. Prognostic effect of estrogen receptor status across age in primary breast cancer. Int J Cancer. 2008 Mar 1;122(5):1089-94. doi: 10.1002/ijc.22892.
Results Reference
background
PubMed Identifier
18612148
Citation
Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, Zhang Y, Wang Y, Marcom PK, Marks JR, Febbo PG, Nevins JR, Potti A, Blackwell KL. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol. 2008 Jul 10;26(20):3324-30. doi: 10.1200/JCO.2007.14.2471. Erratum In: J Clin Oncol. 2011 Sep 20;29(27):3721.
Results Reference
background
PubMed Identifier
35594464
Citation
Perachino M, Poggio F, Arecco L, Blondeaux E, Spinaci S, Marrocco C, Levaggi A, Lambertini M. Update on Pregnancy Following Breast Cancer Diagnosis and Treatment. Cancer J. 2022 May-Jun 01;28(3):176-182. doi: 10.1097/PPO.0000000000000599.
Results Reference
derived

Learn more about this trial

Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer

We'll reach out to this number within 24 hrs